volume 14, issue 1, Pe1006792 2018
DOI: 10.1371/journal.ppat.1006792
View full text
Sign up to set email alerts

Abstract: Therapeutic strategies aimed at achieving antiretroviral therapy (ART)-free HIV remission in infected individuals are under active investigation. Considering the vast majority of HIV-infected individuals experience plasma viral rebound upon cessation of therapy, clinical trials evaluating the efficacy of curative strategies would likely require inclusion of ART interruption. However, it is unclear what impact short-term analytical treatment interruption (ATI) and subsequent reinitiation of ART have on immunolo…

Expand abstract